adenosine monophosphate has been researched along with Cholera Infantum in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Brown, JC; Cordova, FC; Criner, GJ; Galli, JA; Mamary, AJ; Marchetti, N; Mulhall, PD; Myers, CN; Scott, JH; Sehgal, S; Shenoy, KV; Shigemura, N | 1 |
1 other study(ies) available for adenosine monophosphate and Cholera Infantum
Article | Year |
---|---|
COVID-19 in lung transplant recipients.
Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Cough; COVID-19; Cross Infection; Cystic Fibrosis; Dyspnea; Female; Fever; Gastrointestinal Diseases; Glucocorticoids; Graft Rejection; Humans; Idiopathic Pulmonary Fibrosis; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Interleukin 1 Receptor Antagonist Protein; Lung; Lung Transplantation; Male; Methylprednisolone; Middle Aged; Pancreatitis, Acute Necrotizing; Pulmonary Disease, Chronic Obstructive; Pulse Therapy, Drug; SARS-CoV-2; Sepsis; Severity of Illness Index; Tomography, X-Ray Computed | 2020 |